Triazole Fluke and Worm Drench

البلد: أيرلندا

اللغة: الإنجليزية

المصدر: HPRA (Health Products Regulatory Authority)

العنصر النشط:

Levamisole hydrochloride ; Rafoxanide

متاح من:

Pharvet (Ireland) Limited

ATC رمز:

QP52AE51

INN (الاسم الدولي):

Levamisole hydrochloride ; Rafoxanide

جرعة:

15.0, 22.5 milligram(s)/millilitre

الشكل الصيدلاني:

Oral suspension

نوع الوصفة الطبية :

POM: Prescription Only Medicine as defined in relevant national legislation

المجموعة العلاجية:

Cattle, Sheep

المجال العلاجي:

levamisole, combinations

الخصائص العلاجية:

Endoparasiticide

الوضع إذن:

Authorised

تاريخ الترخيص:

1989-10-01

خصائص المنتج

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Triazole Fluke and Worm Drench
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES
Levamisole Hydrochloride
15 mg
Rafoxanide
22.5 mg
EXCIPIENTS
Sodium Metabisulphite (E223)
0.5 mg
Propyl Parahydroxybenzoate(E216)
0.1 mg
Methyl Parahydroxybenzoate(E218)
1.0 mg
Quinoline Yellow (E104)
0.09 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension
A yellow aqueous oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_Triazole _
is a combination product for the treatment of the common nematode
parasites (including lung worm
-
_Dictyocaulus _
spp.) and liver fluke (
_Fasciola hepatica) _
of cattle and sheep.
Triazole is active against:
_Fasciola hepatica _
(mature and immature over 8 weeks of age)
_Nematodirus _
spp.
_Dictyocaulus _
spp.
_Ostertagia _
spp. (except inhibited ostertagia larvae)
4.3 CONTRAINDICATIONS
Do not use in concurrent treatment with organophosphates and / or
diethylcarbamazine.
Do not use in animals with known hypersensitivity to the active
ingredients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk of development of
resistance and could ultimately result in ineffective therapy:
- Too frequent and repeated use of anthelmintics from the same class,
over an extended period of time.
- Underdosing which may be due to underestimation of bodyweight,
misadministration of the product, or
lack of calibration of the dosing device.
Suspected clinical cases of resistance to anthelmintics should be
further investigated using appropriate tests
(e.g. Faecal Egg Count Reduction Test). Where the results of the tests
strongly suggest resistance to a
particular anthelmintic, an anthelmintic belonging to another
pharmacological class and having a different
mode of action should be used.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIA